OREANDA-NEWS. ValiRx Plc (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, is pleased to announce that Satu Vainikka, Chief Executive will be presenting to investors at the free-to-attend Shares Investor Evening in London on Tuesday, 15 December 2015.

The Investor Evening will take place at Novotel Tower Bridge, 10 Pepys Street, London, EC3N 2NR between 18:00 and 20:30 with presentations starting at 18:30.

The Shares Investor Evenings are designed to showcase dynamic companies and provide an opportunity for investors to meet directly with management.

For more information, visit http://www.sharesmagazine.co.uk/events/event/shares-investor-evening-15-dec-15/presenting/